Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Canton Strategic Holdings, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Canton Strategic Holdings, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($172.1M and $166.6M). Across the 9 metrics below, Canton Strategic Holdings, Inc. leads on 7 and Zentalis Pharmaceuticals, Inc. on 2.

Valuation

Metric CNTN ZNTL Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 0.92 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.34 0.65
EV/Sales n/m n/m 8.98
Earnings yield (47.53%) (114.04%) (34.89%)
Free cash flow yield (5.32%) (104.95%) (24.52%)

Profitability

Metric CNTN ZNTL Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) (66.75%) (50.12%)
Return on assets (34.60%) (49.22%) (45.60%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN ZNTL Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 88.10% 18.03% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 4.82 4.89
Net debt to EBITDA 0.85 1.59 1.01

Dividend

Metric CNTN ZNTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTN ZNTL Biotechnology median
Market cap 172.11m 166.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack